+高级检索
首页 > 过刊浏览>2021年第20卷第11期 >866-870. DOI:10.11915/j.issn.1671-5403.2021.11.182
PDF HTML阅读 XML下载 导出引用 引用提醒
非空腹血脂与动脉粥样硬化性心血管疾病发生及预后关系的研究进展
作者:
作者单位:

(1. 华南理工大学医学院,广州 510006;2. 广东省医学科学院·广东省人民医院广东省心血管病研究所高血压研究室,广州 510080)


Progress on association of non-fasting lipid profiles with occurrence and prognosis of atherosclerotic cardiovascular disease
Author:
Affiliation:

(1. School of Medicine, South China University of Technology, Guangzhou 510006, China;2. Hypertension Research Laboratory, Guangdong Cardiovascular Institute, Guangdong Provincial People′s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China)

  • 摘要
    • | |
  • 访问统计
    • |
  • 参考文献 [33]
    • |
  • 相似文献 [20]
    • | | |
  • 文章评论

    【摘要】动脉粥样硬化性心血管疾病(ASCVD)是危害人类健康最主要的慢性非传染性疾病之一,尽管既往大量研究表明空腹血脂与ASCVD发生及其预后密切相关,但空腹血脂检测在临床上有一定的局限性。近年来研究发现,非空腹血脂对ASCVD的发生及预后也有重要作用,且相比空腹血脂,非空腹血脂检测能反映人体一天中大部分时间的血脂水平,更方便快捷。因此,本文就非空腹血脂的定义、优缺点、使用范围及其与ASCVD发生及预后关系的研究进展、致动脉粥样硬化的可能机制进行综述,以期为临床实践提供指导。

    基金项目:广东省重点领域研发计划项目(2019B020227005)；广东省基础与应用基础研究基金项目(2020A1515010738)；广州市科技计划项目(201803040012)

    【Abstract】Atherosclerotic cardiovascular disease (ASCVD) is one of the most important chronic noncontagious diseases that does harm to human health. Although lots of previous studies have reported that fasting lipid profiles are closely related to the occurrence and prognosis of ASCVD, fasting lipid test has some limitations in clinical practice. In recent years, evidence shows that non-fasting lipid profiles also play an important role in the occurrence and prognosis of ASCVD. Compared to fasting lipid test, non-fasting lipid test can reflect the blood lipid levels of human body at most of the time, more rapidly and conveniently. Therefore, this article reviews the definition, relative merits and scope of application of non-fasting lipid profiles, research progress of the relationship between the profiles and the occurrence and prognosis of ASCVD, and possible mechanism for atherosclerosis, in order to provide guidance in clinical practice.

    This work was supported by the Key Area Research & Development Program of Guangdong Province (2019B020227005), the Fundamentaland Applied Basic Research Foundation Project of Guangdong Province ( 2020A1515010738), and the Science and Technology PlanProgram of Guangzhou (201803040012).

    参考文献
    [1] Stone NJ, Robinson JG, Lichtenstein AH, et al.2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol, 2014,63(25 Pt B):2889-2934.DOI:10.1016/j.jacc.2013.11.002.
    [2] Joint Committee for Guideline Revision.2016 Chinese guidelines for the management of dyslipidemia in adults[J].J Geriatr Cardiol, 2018,15(1):1-29.DOI:10.11909/j.issn.1671-5411.2018.01.011.
    [3] Mora S, Rifai N, Buring JE, et al.Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events[J].Circulation, 2008,118(10):993-1001.DOI:10.1161/CIRCULATIONAHA.108.777334.
    [4] Mora S.Nonfasting for routine lipid testing:from evidence to action[J].JAMA Intern Med, 2016,176(7):1005.DOI:10.1001/jamainternmed.2016.1979.
    [5] Langsted A, Nordestgaard BG.Nonfasting versus fasting lipid profile for cardiovascular risk prediction[J].Pathology, 2019,51(2):131-141.DOI:10.1016/j.pathol.2018.09.062.
    [6] Kolovou GD, Mikhailidis DP, Kovar J, et al.Assessment and clinical relevance of non-fasting and postprandial triglycerides:an expert panel statement[J].Curr Vasc Pharmacol, 2011,9(3):258.DOI:10.2174/157016111795495549.
    [7] Freiberg JJ, Tybjrg-Hansen A, Jensen JS, et al.Nonfasting triglycerides and risk of ischemic stroke in the general population[J].JAMA, 2008,300(18):2142-2152.DOI:10.1001/jama.2008.621.
    [8] Iso H, Imano H, Yamagishi K, et al.Fasting and non-fasting triglycerides and risk of ischemic cardiovascular disease in Japanese men and women:the Circulatory Risk in Communities Study (CIRCS)[J].Atherosclerosis, 2014,237(1):361-368.DOI:10.1016/j.atherosclerosis.2014.08.028.
    [9] Doran B, Guo Y, Xu J, et al.Prognostic value of fasting versus nonfasting low-density lipoprotein cholesterol levels on long-term mortality:insight from the National Health and Nutrition Examination Survey Ⅲ (NHANES-Ⅲ)[J].Circulation, 2014,130(7):546-553.DOI:10.1161/CIRCULATIONAHA.114.010001.
    [10] Nordestgaard BG, Langsted A, Mora S, et al.Fasting is not routinely required for determination of a lipid profile:clinical and laboratory implications including flagging at desirable concentration cutpoints — a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine[J].Clin Chem, 2016,62(7):930-946.DOI:10.1373/clinchem.2016.258897.
    [11] Stein EA.Measuring LDL cholesterol:for old and new calculations, is there an optimal formula?[J].Clin Chem, 2014,60(12):1466-1468.DOI:10.1373/clinchem.2014.232793.
    [12] Robson J.Lipid modification:cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease[J].Heart, 2008,94(10):1331-1332.DOI:10.1136/hrt.2008.150979.
    [13] Anderson TJ, Grégoire J, Pearson GJ, et al.2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult[J].Can J Cardiol, 2016,32(11):1263-1282.DOI:10.1016/j.cjca.2016.07.510.
    [14] Jellinger PS.American Association of Clinical Endocrinologists/American College of Endocrinology management of dyslipidemia and prevention of cardiovascular disease clinical practice guidelines[J].Diabetes Spectrum, 2018,31(3):234-245.DOI:10.2337/ds18-0009.
    [15] Grundy SM, Stone NJ, Bailey AL, et al.2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J].J Am Coll Cardiol, 2019, 73(24):e285-e350.DOI:10.1016/j.jacc.2018.11.003.
    [16] Driver SL, Martin SS, Gluckman TJ, et al.Fasting or nonfasting lipid measurements:it depends on the question[J].J Am Coll Cardiol, 2016,67(10):1227-1234.DOI:https://doi.org/10.1016/j.jacc.2015.12.047.
    [17] Bansal S, Buring JE, Rifai N,et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women[J]. JAMA, 2007, 298 ( 3): 309 - 316. DOI: 10. 1001 / jama. 298. 3. 309.
    [18] Emerging Risk Factors Collaboration, Di Angelantonio E, Sarwar N, et al. Major lipids, apolipoproteins, and risk of vascular disease[J]. JAMA, 2009, 302(18): 1993-2000. DOI: 10. 1001/ jama. 2009. 1619.
    [19] Langsted A, Freiberg JJ, Tybjaerg-Hansen A, et al. Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up [ J]. J Intern Med, 2011, 270 ( 1): 65-75. DOI: 10. 1111 / j. 1365-2796. 2010. 02333. x.
    [20] Mora S, Chang CL, Moorthy MV, et al. Association of nonfasting vs fasting lipid levels with risk of major coronary events in the Anglo-Scandinavian cardiac outcomes trial-lipid lowering arm[J]. JAMA Intern Med, 2019, 179 ( 7): 898 - 905. DOI: 10. 1001 / jamainternmed. 2019. 0392.
    [21] Nordestgaard BG, Benn M, Schnohr P, et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease,and death in men and women[J]. JAMA, 2007, 298(3): 299-308. DOI: 10. 1001 / jama. 298. 3. 299.
    [22] Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and therisk of coronary heart disease: 10,158 incident cases among 262,525participants in 29 Western prospective studies [ J]. Circulation,2007, 115(4): 450-458. DOI: 10. 1161 / CIRCULATIONAHA.106. 637793.
    [23] Varbo A, Freiberg JJ, Nordestgaard BG. Extreme nonfastingremnant cholesterol vs extreme LDL cholesterol as contributors tocardiovascular disease and all-cause mortality in 90 000 individualsfrom the general population[J]. Clin Chem, 2015, 61(3): 533-543. DOI: 10. 1373 / clinchem. 2014. 234146.
    [24] Kang K, Lee JJ, Park JM, et al. High nonfasting triglyceride concentrations predict good outcome following acute ischaemic stroke[J].Neurol Res, 2017, 39(9): 779-786. DOI: 10. 1080 / 01616412.2017. 1349567.
    [25] 崔琴, 湛彦强, 胡丹, 等. 非空腹甘油三酯与急性脑梗死预后的关系[J]. 神经损伤与功能重建, 2019, 14(11): 547-550.DOI: 10. 16780 / j. cnki. sjssgncj. 2019. 11. 003.Cui Q, Zhan YQ, Hu D, et al. Correlation between non-fastingtriglyceride level and prognosis of acute cerebral infarction [ J].Neural Inj Funct Reconstr, 2019, 14(11): 547-550. DOI: 10.16780 / j. cnki. sjssgncj. 2019. 11. 003.
    [26] Sigvant B, Lundin F, Wahlberg E. The risk of disease progression inperipheral arterial disease is higher than expected: a meta-analysis ofmortality and disease progression in peripheral arterial disease[ J].Eur J Vasc Endovasc Surg, 2016, 51( 3): 395- 403. DOI: 10.1016 / j. ejvs. 2015. 10. 022.
    [27] Kablak-Ziembicka A, Przewlocki T. Clinical significance of carotidintima-media complex and carotid plaque assessment by for the prediction of adverse cardiovascular events in primary andsecondary care patients[J]. J Clin Med, 2021, 10( 20): 4628.DOI: 10. 3390 / jcm10204628.
    [28] Miura Y, Suzuki Y, Kanamaru H,et al. Higher non-fasting serumtriglyceride preceding the carotid stenosis progression[ J]. NeurolMed Chir ( Tokyo), 2021, 61 ( 7): 422 - 432. DOI: 10. 2176 /nmc. oa. 2020-0430.
    [29][ 29] Miura Y, Kanamaru H, Yasuda R,et al. Nonfasting triglyceride asan independent predictor of carotid restenosis after carotid endarterectomy or carotid artery stenting[ J]. World Neurosurg, 2021,S1878 - 8750 ( 21 ) 01434 - 0. DOI: 10. 1016 / j. wneu. 2021.09. 091.
    [30] Wang L, Gill R, Pedersen TL, et al. Triglyceride-rich lipoproteinlipolysis releases neutral and oxidized FFAs that induce endothelialcell inflammation[ J]. J Lipid Res, 2009, 50 ( 2): 204 - 213.DOI: 10. 1194 / jlr. M700505-JLR200.
    [31] Nordestgaard BG. Triglyceride-rich lipoproteins and atheroscleroticcardiovascular disease: new insights from epidemiology, genetics,and biology[J]. Circ Res, 2016, 118(4): 547-563. DOI: 10.1161 / CIRCRESAHA. 115. 306249.
    [32] Stalenhoef AF, de Graaf J. Association of fasting and nonfastingserum triglycerides with cardiovascular disease and the role ofremnant-like lipoproteins and small dense LDL[J]. Curr Opin Lipidol,2008, 19(4): 355-361. DOI: 10. 1097/ MOL. 0b013e328304b63c.
    [33] Gotto AM, Brinton EA. Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease[J]. J AmColl Cardiol, 2004, 43(5): 717-724. DOI: 10. 1016/ j. jacc. 2003. 08.061.ultrasound
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

程淇,黄雨晴,冯颖青.非空腹血脂与动脉粥样硬化性心血管疾病发生及预后关系的研究进展[J].中华老年多器官疾病杂志,2021,20(11):866-870

复制
分享
文章指标
  • 点击次数:202
  • 下载次数: 380
  • HTML阅读次数: 0
  • 引用次数: 0
历史
  • 收稿日期:2020-11-30
  • 在线发布日期: 2021-11-29
文章二维码
您是第4226002 位访问者
主管单位：中国人民解放军总医院
主办单位：解放军总医院医学创新研究部、国家老年疾病临床医学研究中心（解放军总医院）、解放军总医院第六医学中心心血管病医学部
地址：北京市复兴路28号《中华老年多器官疾病杂志》编辑部
电话：010-66936756
中华老年多器官疾病杂志 ® 2025 版权所有 技术支持：北京勤云科技发展有限公司